Loading provider…
Loading provider…
Internal Medicine Physician in Houston, TX
NPI: 1124273990Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get M.D. Rashmi's Phone Numberphone_androidMobile
Get M.D. Rashmi's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
AZ State Medical License
2023 - 2027
GA State Medical License
2023 - 2027
TN State Medical License
2023 - 2027
LA State Medical License
2023 - 2026
MS State Medical License
2023 - 2026
TX State Medical License
2010 - 2026
WA State Medical License
2023 - 2026
AL State Medical License
2023 - 2025
OK State Medical License
2023 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
University of Texas Health Science Center at Houston/M D Anderson Cancer Center
Fellowship • Hematology and Medical Oncology
2011 - 2014
University of Pennyslvania
Masters • Bioethics
2003 - 2004
Heersink School of Medicine - Birmingham
uab.edu
Medical School
Until 2008
University of Alabama-Birmingham
BA • Philosophy
2000 - 2003
Baylor College Of Medicine
bcm.edu
Residency • Internal Medicine
2008 - 2011
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 35 | 62 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 33 | 61 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 31 | 31 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 29 | 54 |
Authors: Laura Esserman, Elissa Price, John Park, Michelle Melisko, Erica Stringer-Reasor, Amy Chien, Angela Demichele, Hyo Han, Judy Boughey, Anne Wallace, Barbara Haley, Rita Nanda, Andres Forero-Torres, Erin Ellis, Amy Clark, Anthony Elias, Julie Lang, Rachel Yung, Douglas Yee, Heather Beckwith, Bonnie Joe, Hope Rugo, Barbara Parker
Journal: NPJ Breast Cancer
Publication Date: 2022-12-01
Authors: Larissa Meyer, Gordon Mills, Pamela Soliman, Jennifer Litton, Kathleen Schmeler, Shannon Westin, Karen Lu, Robert Coleman, Amir Jazaeri, Jinsong Liu, Anil Sood
Journal: Clin Cancer Res
Publication Date: 2021-09-13
Authors: Naoto Ueno, Sharon Giordano, Aysegul Sahin, Mariana Chavez Mac Gregor
Journal: Br J Cancer
Publication Date: 2017-01-12
Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Intervention / Treatment: DRUG: trastuzumab deruxtecan, DRUG: tucatinib
Lead Sponsor: Hoffmann-La Roche
Intervention / Treatment: DRUG: ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1c, DRUG: ZN-A-1041, DRUG: ZN-A-1041 + T-DM1 3.6 mg/kg iv. for Phase 1b, DRUG: ZN-A-1041 + T-Dxd 5.4 mg/kg iv. for Phase 1b, DRUG: ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1b, DRUG: ZN-A-1041 + T-DM1 3.6 mg/kg iv. for Phase 1c, DRUG: ZN-A-1041 + T-Dxd 5.4 mg/kg iv. for Phase 1c
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Bintrafusp Alfa